ScienceDex / Researcher record
Keedy, Kara S
- Aimmax Therapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2022 | $306,486 | 1 | #33,831 |
| 2023 | $613,362 | 2 | #19,736 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20221 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award records by amount
NIH award records listing Keedy, Kara S as a PI. Multi-PI records show the full award amount for context.
- 1R43AI174384-01A1R43Contact PIDevelopment of a Novel Injectable Antibiotic to Treat Serious Multidrug-resistant Gram-positive Infections$307Kaward amount
- 5R43AI164986-02R43Contact PIOptimization and Characterization of Novel Antifungal Peptides$306.4Kaward amount
Award organization
Organizations that administered FY2023 awards listing Keedy, Kara S as a PI.
FY2023 award administered by Aimmax Therapeutics, Inc. (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardAimmax Therapeutics, Inc.
- 2023$500K Cumulative Funding